Gadolinium-based MRI contrast agents are deemed safe to use in diagnostic exams. Their use would bring value to radiation oncology applications such as daily replanning on the MR-Linac. However, their stability and safe use in the presence of high-energy radiation remains unknown. We analyzed the chemical composition stability of two common MRI contrast agents that were irradiated to various doses using mass spectrometry. We found no detectable amounts of degradation compounds or conformational alterations as a result of irradiation. This is the first step towards demonstrating the safe use of gadolinium-based MRI contrast agents in radiation oncology applications.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords